| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3911 |
| Trial ID | NCT06465147 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SCRI-CAR19v3 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | REACT-01: Reversing Autoimmunity Through Cell Therapy |
| Year | 2024 |
| Country | United States |
| Company sponsor | Seattle Children's Hospital |
| Other ID(s) | REACT-01 |
| Cohort 1 | |||||||
|
|||||||